Femasys (FEMY) Enterprise Value (2021 - 2026)
Femasys' (FEMY) quarterly Enterprise Value came in at $11.2 million in Q2 2026, down 60.36% on a YoY basis from $28.2 million in Q2 2025, and down 43.99% quarter-over-quarter from $20.0 million in Q1 2026.
Analysis
Femasys (FEMY) Enterprise Value (2021 - 2026) Analysis & Trends
Femasys (FEMY) has reported Enterprise Value for 6 consecutive years, with $11.2 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Enterprise Value fell 60.36% year-over-year to $11.2 million; the trailing twelve-month figure through Jun 2026 stood at $11.2 million (down 60.36% YoY), and the FY2025 full-year result was $13.5 million, down 39.2% from the prior year.
- Enterprise Value fell to $11.2 million in Q2 2026 per FEMY's latest filing, from $20.0 million in the prior quarter.
- Across five years, Enterprise Value topped out at $39.0 million in Q3 2023 and bottomed at -$6.7 million in Q4 2023.
- Historically, Enterprise Value has averaged $12.4 million across 5 years, with a median of $12.0 million in 2024.
- The sharpest annual moves came in 2022 and 2023: Enterprise Value sank 263.52% in 2022, then soared 1566.95% in 2023.
- Over 5 years, Enterprise Value stood at -$2.3 million in 2022, then slumped by 194.68% to -$6.7 million in 2023, then jumped by 431.13% to $22.2 million in 2024, then slumped by 39.2% to $13.5 million in 2025, then dropped by 17.2% to $11.2 million in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered $11.2 million, $20.0 million, and $13.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Femasys | 9.37 Mn | 7.92 Mn | 189,391.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.20 Mn |
| Mar 31, 2026 | 19.99 Mn |
| Dec 31, 2025 | 13.52 Mn |
| Sep 30, 2025 | 12.10 Mn |
| Jun 30, 2025 | 28.24 Mn |
| Mar 31, 2025 | 30.04 Mn |
| Dec 31, 2024 | 22.24 Mn |
| Sep 30, 2024 | 17.07 Mn |
| Jun 30, 2024 | 11.82 Mn |
| Mar 31, 2024 | 16.42 Mn |
| Dec 31, 2023 | -6.72 Mn |
| Sep 30, 2023 | 38.97 Mn |
| Jun 30, 2023 | -3.02 Mn |
| Mar 31, 2023 | 2.72 Mn |
| Dec 31, 2022 | -2.28 Mn |
| Sep 30, 2022 | -2.66 Mn |
| Jun 30, 2022 | 9.35 Mn |
| Mar 31, 2022 | 4.91 Mn |
| Dec 31, 2021 | 1.39 Mn |
| Sep 30, 2021 | 54.02 Mn |